Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
Systematic review |
46 people Data from 1 RCT |
Proportion of people withdrawing from an RCT
8 weeks
8/25 (32%) with amitriptyline 5/21 (25%) with placebo |
RR 1.34 95% CI 0.52 to 3.49 Known adverse effects of tricyclic antidepressants include anticholinergic effects (see harms of prescription antidepressant drugs in review on depression in adults [drug and other physical treatments]) |
Not significant | |
Systematic review |
41 people Data from 1 RCT |
Proportion of people withdrawing from an RCT
8 weeks
12/23 (52%) with imipramine 12/18 (67%) with placebo |
RR 0.78 95% CI 0.47 to 1.3 Known adverse effects of tricyclic antidepressants include anticholinergic effects (see harms of prescription antidepressant drugs in review on depression in adults [drug and other physical treatments]) |
Not significant |